Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu to Distribute Phenomenome Discoveries Software Worldwide

NEW YORK, Oct. 19 (GenomeWeb News) - Phenomenome Discoveries, a Canadian company that provides software tools for metabolomics analysis, said this week that Tokyo-based Shimadzu will become the global distributor for its Phenomenome Profiler software.

 

Under the agreement, Shimadzu will co-market and distribute PDI's software together with its mass spectrometry product lines for GC/MS and LC/MS.

 

Financial details were not discussed.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.